2-amino-1-(4-nitro-phenyl)-ethanone | 4740-22-1

• 分子结构分类: 有机化合物 - 有机氧化合物
• 英文名称: 2-amino-1-(4-nitro-phenyl)-ethanone
• 英文别名: 4-(α-aminoacetyl)-1-nitrobenzene；2-amino-1-(4-nitrophenyl)ethanone；N-(p-nitrophenacyl)-amine；2-Amino-1-(4-nitro-phenyl)-aethanon；(Aminomethyl)-(4-nitrophenyl)-keton；α-Amino-p-nitro-acetophenon
• CAS: 4740-22-1
• 化学式: C₈H₈N₂O₃
• 分子量: 180.163
• InChiKey: QGMHMZOHCYYHBA-UHFFFAOYSA-N

物化性质

• 熔点：
  134 °C
• 沸点：
  90 °C
• 密度：
  1.320±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  0.6
• 重原子数：
  13
• 可旋转键数：
  2
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.12
• 拓扑面积：
  88.9
• 氢给体数：
  1
• 氢受体数：
  4

安全信息

• 危险品标志：
  Xi
• 危险类别码：
  R34
• 海关编码：
  2924199090
• 安全说明：
  S26,S36/37/39,S45

SDS

Name:	2-Amino-1-(4-nitrophenyl)ethan-1-one hydrochloride hydrate 97% Material Safety Data Sheet
Synonym:	4-Nitrophenylacylamin
CAS:	4740-22-1

Section 1 - Chemical Product MSDS Name:2-Amino-1-(4-nitrophenyl)ethan-1-one hydrochloride hydrate 97% Material Safety Data Sheet
Synonym:4-Nitrophenylacylamin

---

Section 2 - COMPOSITION, INFORMATION ON INGREDIENTS

CAS#	Chemical Name	content	EINECS#
4740-22-1	2-Amino-1-(4-nitrophenyl)ethan-1-one h	97%	unlisted

Hazard Symbols: C
Risk Phrases: 34

---

Section 3 - HAZARDS IDENTIFICATION
EMERGENCY OVERVIEW
Causes burns.
Potential Health Effects
Eye:
Causes eye burns.
Skin:
Causes skin burns.
Ingestion:
Causes gastrointestinal tract burns.
Inhalation:
Causes chemical burns to the respiratory tract.
Chronic:
Not available.

---

Section 4 - FIRST AID MEASURES
Eyes: Immediately flush eyes with plenty of water for at least 15 minutes, occasionally lifting the upper and lower eyelids. Get medical aid immediately.
Skin:
Get medical aid immediately. Immediately flush skin with plenty of water for at least 15 minutes while removing contaminated clothing and shoes.
Ingestion:
Do not induce vomiting. Get medical aid immediately.
Inhalation:
Get medical aid immediately. Remove from exposure and move to fresh air immediately. If not breathing, give artificial respiration. If breathing is difficult, give oxygen.
Notes to Physician:
Treat symptomatically and supportively.

---

Section 5 - FIRE FIGHTING MEASURES
General Information:
As in any fire, wear a self-contained breathing apparatus in pressure-demand, MSHA/NIOSH (approved or equivalent), and full protective gear.
Extinguishing Media:
Use foam, dry chemical, or carbon dioxide.

---

Section 6 - ACCIDENTAL RELEASE MEASURES
General Information: Use proper personal protective equipment as indicated in Section 8.
Spills/Leaks:
Vacuum or sweep up material and place into a suitable disposal container.

---

Section 7 - HANDLING and STORAGE
Handling:
Do not breathe dust, vapor, mist, or gas. Do not get in eyes, on skin, or on clothing. Use only in a chemical fume hood.
Storage:
Store in a cool, dry place. Store in a tightly closed container.
Corrosives area.

---

Section 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION
Engineering Controls:
Facilities storing or utilizing this material should be equipped with an eyewash facility and a safety shower. Use adequate ventilation to keep airborne concentrations low.
Exposure Limits CAS# 4740-22-1: Personal Protective Equipment Eyes: Not available.
Skin:
Wear appropriate protective gloves to prevent skin exposure.
Clothing:
Wear appropriate protective clothing to prevent skin exposure.
Respirators:
Follow the OSHA respirator regulations found in 29 CFR 1910.134 or European Standard EN 149. Use a NIOSH/MSHA or European Standard EN 149 approved respirator if exposure limits are exceeded or if irritation or other symptoms are experienced.

---

Section 9 - PHYSICAL AND CHEMICAL PROPERTIES

Physical State: Solid
Color: cream
Odor: Not available.
pH: Not available.
Vapor Pressure: Not available.
Viscosity: Not available.
Boiling Point: Not available.
Freezing/Melting Point: 134 deg C
Autoignition Temperature: Not available.
Flash Point: Not available.
Explosion Limits, lower: Not available.
Explosion Limits, upper: Not available.
Decomposition Temperature:
Solubility in water:
Specific Gravity/Density:
Molecular Formula: C8H11ClN2O4
Molecular Weight: 234.64

---

Section 10 - STABILITY AND REACTIVITY
Chemical Stability:
Not available.
Conditions to Avoid:
Incompatible materials.
Incompatibilities with Other Materials:
Oxidizing agents.
Hazardous Decomposition Products:
Hydrogen chloride, chlorine, nitrogen oxides, carbon monoxide, carbon dioxide, acrid smoke and fumes.
Hazardous Polymerization: Has not been reported

---

Section 11 - TOXICOLOGICAL INFORMATION
RTECS#:
CAS# 4740-22-1 unlisted.
LD50/LC50:
Not available.
Carcinogenicity:
2-Amino-1-(4-nitrophenyl)ethan-1-one hydrochloride hydrate - Not listed by ACGIH, IARC, or NTP.

---

Section 12 - ECOLOGICAL INFORMATION

---

Section 13 - DISPOSAL CONSIDERATIONS
Dispose of in a manner consistent with federal, state, and local regulations.

---

Section 14 - TRANSPORT INFORMATION

IATA
Shipping Name: AMINES, SOLID, CORROSIVE, N.O.S.*
Hazard Class: 8
UN Number: 3259
Packing Group: III
IMO
Shipping Name: AMINES, SOLID, CORROSIVE, N.O.S.
Hazard Class: 8
UN Number: 3259
Packing Group: III
RID/ADR
Shipping Name: AMINES, SOLID, CORROSIVE, N.O.S.
Hazard Class: 8
UN Number: 3259
Packing group: III

---

Section 15 - REGULATORY INFORMATION

European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: C
Risk Phrases:
R 34 Causes burns.
Safety Phrases:
S 26 In case of contact with eyes, rinse immediately
with plenty of water and seek medical advice.
S 36/37/39 Wear suitable protective clothing, gloves
and eye/face protection.
S 45 In case of accident or if you feel unwell, seek
medical advice immediately (show the label where
possible).
WGK (Water Danger/Protection)
CAS# 4740-22-1: No information available.
Canada
None of the chemicals in this product are listed on the DSL/NDSL list.
CAS# 4740-22-1 is not listed on Canada's Ingredient Disclosure List.
US FEDERAL
TSCA
CAS# 4740-22-1 is not listed on the TSCA inventory.
It is for research and development use only.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

• 作为反应物：
  描述：

  2-amino-1-(4-nitro-phenyl)-ethanone 在 乙醇 、 aluminum isopropoxide 、 碳酸氢钠 、 异丙醇 作用下， 生成 L-氯霉素
  参考文献：
  名称：

  Chloromycetin.¹ Synthesis of α-Dichloroacetamido-β-hydroxy-p-nitropropiophenone

  摘要：

  DOI：

  10.1021/ja01145a523
• 作为产物：
  描述：

  2-溴-4'-硝基苯乙酮 在 乌洛托品 作用下， 以 二氯甲烷 为溶剂， 反应 1.0h， 以30 g的产率得到2-amino-1-(4-nitro-phenyl)-ethanone
  参考文献：
  名称：

  Evaluation of thiazole containing biaryl analogs as diacylglycerol acyltransferase 1 (DGAT1) inhibitors

  摘要：

  Biphenyl carboxylic acids, exemplified by compound 5, are known potent inhibitors of diacylglycerol acyltransferase, DGAT1, an enzyme involved in the final committed step of triglyceride biosynthesis. We have synthesized and evaluated 2-phenylthiazole, 4-phenylthiazole, and 5-phenylthiazole analogs as DGAT1 inhibitors. The 5-phenylthiazole series exhibited potent DGAT1 inhibition when evaluated using an in vitro enzymatic assay and an in vivo fat tolerance test in mice. Compound 33 (IC50 = 23 nM) exhibiting promising oral pharmacokinetic parameters (AUC(inf) = 7058 ng*h/ml, T-1/2 = 0.83 h) coupled with 87 percent reduction of plasma triglycerides in vivo may serve as a lead for developing newer anti-obesity agents. (C) 2013 Elsevier Masson SAS. All rights reserved.

  DOI：

  10.1016/j.ejmech.2013.05.006

文献信息

• [EN] NAMPT MODULATORS<br/>[FR] MODULATEURS DE NAMPT
  申请人：CYTOKINETICS INC

  公开号：WO2021159015A1

  公开（公告）日：2021-08-12

  Provided are compounds of Formula (II) or a pharmaceutically acceptable salt thereof, wherein R1, R2, R3, R4, R5, R6, and p are as defined herein. Also provided is a pharmaceutically acceptable composition comprising a compound of Formula (II), or a pharmaceutically acceptable salt thereof. Also provided are methods of using a compound of Formula (II), or a pharmaceutically acceptable salt thereof.

  提供了公式（II）的化合物或其药用可接受盐，其中R1、R2、R3、R4、R5、R6和p如本文所定义。还提供了包含公式（II）化合物或其药用可接受盐的药用可接受组合物。还提供了使用公式（II）化合物或其药用可接受盐的方法。
• Preparation of 5-Substituted 2-(2-Alkyl/aryl-1<i>H</i>-imidazol-4-yl)oxazoles and 5-Substituted 2-(2-Alkyl/arylthiazol-4-yl)oxazoles by Utilizing 5-Substituted 2-(2-Bromo-1,1-diethoxyethyl)oxazole as a Synthon
  作者：Denis Laurent、Jeffrey Romine

  DOI：10.1055/s-0028-1088162

  日期：——

  oxazolylimidazoles, -thiazoles, and -oxazoles is gained from a masked α-halo ketone attached to the 2-position of the oxazole ring. 3-Bromo-2,2-diethoxy-N-(2-oxoalkyl)propionamides readily cyclize to generate the key 5-substituted 2-(2-bromo-1,1-diethoxyethyl)oxazole intermediate. 3-bromo-2,2-diethoxypropionic acid - α-halo ketones - cyclizations - heterocycles - oxazoles

  合成恶唑基取代的杂环（包括恶唑基咪唑，-噻唑和-恶唑）的方法是从附在恶唑环2位上的掩蔽α-卤代酮获得。3-溴-2,2-二乙氧基-N-（2-氧代烷基）丙酰胺容易环化以生成关键的5-取代的2-（2-溴-1,1-二乙氧基乙基）恶唑中间体。 3-溴-2,2-二乙氧基丙酸-α-卤代酮-环化-杂环-恶唑
• Sequential cyclizations of 2-isothiocyanatobenzonitrile and 2-isocyanatobenzonitrile with α-aminoketones
  作者：Peter Langer、Anja Bodtke

  DOI：10.1016/s0040-4039(03)01489-8

  日期：2003.8

  Pharmacologically relevant 5-thioxo-6H-imidazo[1,2-c]quinazolines and 5-oxo-6H-imidazo[1,2-c]quinazolines were prepared by sequential reactions of α-aminoketones with 2-isothiocyanatobenzonitrile and 2-isocyanatobenzonitrile, respectively.

  通过α-氨基酮与2-异硫氰酸根合苄腈的顺序反应，制备药理学上相关的5-thioxo-6 H-咪唑并[1,2- c ]喹唑啉和5-oxo-6 H-咪唑并[1,2- c ]喹唑啉。2-异氰基苄腈。
• Substituted Pyrroles, Compositions Containing Same, Method for Making Same and Use Thereof
  申请人：RONAN Baptiste

  公开号：US20080167368A1

  公开（公告）日：2008-07-10

  The disclosure concerns substituted pyrroles of formula (I): wherein A, L, Ar, R1, R2, R5, and Ra are as defined in the disclosure, compositions containing the same, methods for making the same and uses thereof, in particular as anti-cancer agents.

  该公开涉及式(I)的取代吡咯化合物：其中A、L、Ar、R1、R2、R5和Ra如公开中定义，包含这种化合物的组合物，制备这种化合物的方法以及其用途，特别是作为抗癌剂。
• [EN] QUINOLINE DERIVATIVES AND MELK INHIBITORS CONTAINING THE SAME<br/>[FR] DÉRIVÉS DE QUINOLINE ET INHIBITEURS DE MELK LES CONTENANT
  申请人：ONCOTHERAPY SCIENCE INC

  公开号：WO2012016082A1

  公开（公告）日：2012-02-02

  The present invention directs a compound represented by formula (I).

  本发明涉及一种由化学式（I）表示的化合物。